Colgate-Palmolive (NYSE:CL – Get Free Report) had its target price upped by investment analysts at JPMorgan Chase & Co. from $95.00 to $103.00 in a report issued on Monday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price objective suggests a potential upside of 11.47% from the company’s current price.
A number of other analysts also recently issued reports on the stock. TD Cowen dropped their price objective on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a report on Wednesday, January 8th. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $101.00 price target on shares of Colgate-Palmolive in a research note on Wednesday, January 29th. Barclays reduced their price objective on Colgate-Palmolive from $89.00 to $86.00 and set an “equal weight” rating on the stock in a research report on Friday, April 11th. Stifel Nicolaus dropped their target price on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a research report on Monday, February 3rd. Finally, Raymond James reissued an “outperform” rating and set a $105.00 price target (down from $110.00) on shares of Colgate-Palmolive in a research note on Monday, February 3rd. One analyst has rated the stock with a sell rating, nine have given a hold rating and twelve have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $102.39.
Read Our Latest Report on Colgate-Palmolive
Colgate-Palmolive Price Performance
Colgate-Palmolive (NYSE:CL – Get Free Report) last posted its quarterly earnings data on Friday, April 25th. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.86 by $0.05. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. The company had revenue of $4.91 billion for the quarter, compared to analysts’ expectations of $4.92 billion. During the same period in the prior year, the business earned $0.86 earnings per share. Colgate-Palmolive’s revenue for the quarter was down 3.0% compared to the same quarter last year. On average, research analysts forecast that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.
Colgate-Palmolive announced that its board has authorized a share buyback program on Thursday, March 20th that allows the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization allows the company to repurchase up to 6.8% of its shares through open market purchases. Shares repurchase programs are generally a sign that the company’s board of directors believes its shares are undervalued.
Institutional Investors Weigh In On Colgate-Palmolive
Several hedge funds have recently bought and sold shares of the business. Westend Capital Management LLC grew its stake in shares of Colgate-Palmolive by 111.1% in the 1st quarter. Westend Capital Management LLC now owns 266 shares of the company’s stock worth $25,000 after buying an additional 140 shares during the last quarter. Kohmann Bosshard Financial Services LLC purchased a new stake in shares of Colgate-Palmolive in the fourth quarter worth $26,000. Centricity Wealth Management LLC purchased a new position in shares of Colgate-Palmolive in the 4th quarter worth about $27,000. Vermillion Wealth Management Inc. bought a new position in Colgate-Palmolive in the 4th quarter worth about $31,000. Finally, Union Bancaire Privee UBP SA purchased a new stake in Colgate-Palmolive during the 4th quarter valued at about $32,000. Institutional investors own 80.41% of the company’s stock.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Stories
- Five stocks we like better than Colgate-Palmolive
- The 3 Best Blue-Chip Stocks to Buy Now
- Don’t Be Fooled by the Bounce: The Market Storm Isn’t Over Yet
- How to Start Investing in Real Estate
- Coca-Cola Company Stock Can Bubble to New Highs This Year
- EV Stocks and How to Profit from Them
- 3 Stocks Lifting 2025 Guidance Despite Market Jitters
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.